In skeletal muscle, GSK3 disrupts glucose metabolism through interference with insulin signaling and the inhibition of glycogen synthesis, contributing to muscle insulin resistance and impaired glucose utilization in obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.